Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Breast Cancer Patients Undergoing Mastectomy and Reconstruction Suffer More from Chronic Pain

Breast Cancer Patients Undergoing Mastectomy and Reconstruction Suffer More from Chronic Pain

Breast cancer was the reason for mastectomy (surgical removal of breast tissue) plus reconstruction through plastic surgery. Among women undergoing these procedures, those receiving chemotherapy and younger women had a higher chronic controlled substance use risk, according to the report.

What is a chronic controlled substance?

A chronic controlled substance (chronic controlled substance) refers to various medications used to control long-term pain. There are 5 types of these controlled substances: narcotic (opioid, intoxicating) painkillers, antidepressants, stimulants, hallucinogens, and anabolic steroids. However, controlled substances primarily bring to mind narcotic painkillers (such as morphine and tramadol), which are the drugs most commonly used for this purpose. 

2020 San Antonio Breast Cancer Symposium results reported that, among women undergoing mastectomy plus reconstructive surgery, those receiving chemotherapy and younger women had a higher risk of new chronic controlled substance use. .

The findings also emphasize the need for greater attention to patients with mental health and substance use diagnoses when managing pain, anxiety, and sleep disorders.

According to the researchers, approximately 10% of patients reported chronic opioid use for 3 months or longer after surgery. However, previous studies had not evaluated postoperative opioid use in people diagnosed with cancer compared with those without a cancer diagnosis.

The study's lead author, Dr. Jacob Cogan, who works in hematology / oncology in New York, said, "Despite high rates of psychiatric conditions in the cancer patient population, there is very little research on rates of persistent sedative / hypnotic use in these cases".

The researchers therefore aimed to determine rates of new persistent controlled substance use after mastectomy with reconstructive surgery and identify ways to reduce new persistent postoperative use.

The study analyzed data from women older than 18 who underwent mastectomy and reconstruction among 230 million patients between 2008-2017.

Prescriptions for opioids and sedative-hypnotic drugs were identified in 3 time periods:

  • preoperative (365 days to 31 days before surgery; period 1);
  • perioperative (31 days before and 90 days after surgery; period 2), and
  • postoperative (90 days to 365 days after surgery; period 3).

Patients who filled at least 1 controlled substance prescription during period 1 were excluded from the analysis. Those who did not use controlled substances in period 1 but filled at least 1 prescription in period 2 and at least 2 in period 3 were considered new chronic users and compared with other, non-chronic users.

The researchers performed a separate multivariable logistic regression analysis for each drug category to evaluate demographic and clinical factors associated with chronic use risk, including age, region of residence, health insurance, breast cancer diagnosis, chemotherapy, radiation therapy, previous mental health diagnosis, and prior...

In total, the researchers identified 25,270 women who had not used opioid painkillers and 27,651 women who had not used sedative-hypnotics.

Within each group, 13.1% of opioid-naive patients became new chronic users, and 6.6% of the sedative-hypnotic-naive group became new persistent users.

The researchers found a higher risk of chronic controlled substance use in:

  • younger patients (under 60),
  • those with Medicaid health insurance (healthcare provided by the United States government to people below a certain income),
  • those diagnosed with breast cancer,
  • those treated with chemotherapy,
  • those with a mental health diagnosis, and
  • those with a previous substance use diagnosis.

The researchers also found that a patient's risk of becoming a new persistent user increased with the number of identified risk factors. For example, having 5 risk factors (age, Medicaid, Southern region, breast cancer diagnosis, and chemotherapy / radiation therapy) increased the odds of becoming a new persistent opioid user 6.34 (19%) times, and the odds of becoming a new persistent sedative / hypnotic user 7.71 (10.5%) times.

Conclusion & Commentary

These findings reflect information we had previously observed but which had not been well reported until now. Which patients should we pay attention to?

First, we should pay attention to patients scheduled for or having undergone mastectomy and reconstruction for early-stage breast cancer, especially younger patients receiving chemotherapy. Breast reconstruction does not necessarily have to be performed with breast cancer surgery; safe, favorable results can also be achieved later. The follow-up physician should also ask whether the patient is still taking opioid painkillers or sedative medications.

Sources

Cogan JC, Raghunathan RR, Beauchemin MP, et al. Persistent controlled substance use following mastectomy with reconstruction surgery. Presented at: 2020 San Antonio Breast Cancer Symposium; December 8, 2020; Virtual. Abstract GS3-08.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Breast Cancer Patients Undergoing Mastectomy and Reconstruction Suffer More from Chronic Pain

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy